GeminIQ Website Logo

Viewing TWST free

Subscribe for full history, 90+ metrics, screener, watchlist...

Twist Bioscience Corp

TWST

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
117123149183201210221226239243266286
Short Term Investments
494949494947495050504550
Accounts Receivable Net Current
656450575050393532363544
Inventory Net
353433282621242428303132
Prepaid Expense And Other Assets Current
545423151310121112121312
Assets Current
321323304333340338345347362372390424
Property Plant And Equipment Net
1121111051029597101103106121126132
Operating Lease Right Of Use Asset
697172495254565961646972
Equity Securities F V N I Noncurrent
6868545454--2----
Goodwill
828282828286868686868686
Finite Lived Intangible Assets Net
131313131414141415525354
Restricted Cash Noncurrent
222233333333
Other Assets Noncurrent
555544325556
Assets
672676638642644596609614638703733776
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
171512111288278914
Employee Related Liabilities Current
352719312925223432252126
Accrued Liabilities Current
-2523232020201515151411
Operating Lease Liability Current
91012141615151515151515
Other Liabilities Current
60681312117566568
Liabilities Current
12012080918775707174676573
Operating Lease Liability Noncurrent
858586626365687073757779
Other Long Term Debt
151515151515150----
Other Liabilities Noncurrent
611110001000
Liabilities
227221182169165156153142147143143153
Stockholders Equity
Common Stock Value
000000000000
Additional Paid In Capital
1,8761,8501,8071,7931,7721,7541,7301,7151,6991,6821,6671,657
Accumulated Other Comprehensive Income Loss Net Of…
-1-1-1-1-1-1-1-1-1-1-1-1
Retained Earnings Accumulated Deficit
-1,429-1,394-1,350-1,320-1,292-1,313-1,274-1,242-1,207-1,122-1,076-1,033
Stockholders Equity
446455456473478440456473491560590623
Liabilities And Stockholders Equity
672676638642644596609614638703733776
Related Party
--111--1----
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
200200200200200200100100100100100100
Shares Outstanding
636261616060605959585858
Common Stock Shares Issued
636261616060605959585858

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20260.23%-4.87%30.19%19.01%77.68%60.65%------
2025-26.41%-23.49%-23.96%-18.45%0.00%0.17%-10.72%-10.92%12.91%16.89%33.48%86.09%
20244.40%-5.44%-23.61%31.93%59.23%68.38%1.61%8.08%9.22%14.65%5.24%26.24%
2023-------0.80%-14.69%-36.38%45.97%52.34%61.07%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
2.67
2.70
3.78
3.64
3.90
4.51
4.96
4.88
4.91
5.51
5.98
5.79
Quick Ratio
1.93
1.97
3.08
3.17
3.45
4.10
4.45
4.38
4.36
4.88
5.31
5.19
Working Capital
201.04M
203.46M
223.44M
241.56M
252.71M
263.47M
275.66M
275.77M
288.07M
304.38M
325.00M
350.93M
Leverage & Debt
Debt to Equity
0.51
0.49
0.40
0.36
0.35
0.35
0.33
0.30
0.30
0.25
0.24
0.25
Interest Coverage TTM
-
-
-940.66
-815.92
-726.36
-1,026.37
-3,933.92
-7,614.86
-234,899.00
-103,379.00
-54,876.50
-43,431.80
Debt Ratio
0.34
0.33
0.29
0.26
0.26
0.26
0.25
0.23
0.23
0.20
0.19
0.20
Efficiency & Turnover
Asset Turnover TTM
0.66
0.64
0.63
0.60
0.57
0.54
0.49
0.45
0.41
0.36
0.32
0.28
Days Sales Outstanding TTM
48.57
50.85
41.66
44.55
41.23
45.11
41.27
46.05
46.10
55.36
55.50
62.81
Receivables Turnover TTM
7.52
7.18
8.76
8.19
8.85
8.09
8.84
7.93
7.92
6.59
6.58
5.81
Per Share Metrics
Diluted EPS TTM
-2.19
-1.32
-1.25
-1.30
-1.39
-3.20
-3.34
-3.60
-3.79
-3.33
-3.58
-3.60
Free Cash Flow Per Share TTM
-1.49
-1.54
-1.42
-1.26
-1.15
-1.10
-1.16
-1.19
-1.29
-1.65
-2.24
-2.99
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
51.97%
52.07%
51.62%
50.72%
49.24%
46.70%
44.59%
42.61%
40.53%
38.29%
35.79%
36.61%
Operating Profit Margin TTM
-33.58%
-33.90%
-34.35%
-36.18%
-39.30%
-57.86%
-63.15%
-70.56%
-79.57%
-74.51%
-83.66%
-88.60%
Net Profit Margin TTM
-31.66%
-19.85%
-19.56%
-20.63%
-23.51%
-54.98%
-59.76%
-66.69%
-74.63%
-69.24%
-78.44%
-83.48%
Growth Metrics
Net Revenue Growth (1Y)
19.19%
17.77%
18.59%
20.32%
22.72%
25.30%
25.85%
27.69%
25.37%
21.79%
21.58%
20.41%
Net Income Growth (1Y)
60.49%
-57.48%
-61.19%
-62.79%
-61.33%
-0.52%
-4.13%
2.01%
5.17%
-9.63%
-3.89%
-6.08%
EPS Growth (1Y)
54.30%
-58.89%
-62.41%
-63.90%
-62.53%
-3.63%
-6.82%
0.02%
3.17%
-11.20%
-5.65%
-11.03%
Valuation Metrics
P/E TTM
-46.96
-36.08
-25.30
-21.67
-25.91
-12.25
-13.93
-12.56
-13.01
-10.32
-10.30
-5.63
P/B TTM
14.40
6.44
4.25
3.56
4.62
5.32
6.03
5.55
5.83
3.54
3.59
1.85
P/S TTM
14.87
7.16
4.95
4.47
6.09
6.74
8.33
8.38
9.71
7.14
8.08
4.70
Market Cap
6.42B
2.93B
1.94B
1.68B
2.21B
2.34B
2.75B
2.62B
2.87B
1.98B
2.12B
1.15B
Enterprise Value
6.30B
2.81B
1.79B
1.50B
2.00B
2.13B
2.53B
2.39B
2.62B
1.74B
1.85B
863.21M
Calculated Values
Free Cash Flow TTM
-93.12M
-95.04M
-86.72M
-75.63M
-68.71M
-65.49M
-68.39M
-69.17M
-74.95M
-95.52M
-128.84M
-170.25M
Net Debt
-119.57M
-124.85M
-150.99M
-185.43M
-203.91M
-212.95M
-224.06M
-229.13M
-242.04M
-246.22M
-269.12M
-289.28M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-25Sale
Owner: Leproust, Emily M.
Title: Chief Executive Officer
Shares: 18,880
Price/Share: $95.00
Value: $1,793,600.00
Shares Owned: 824,039
Relationship: Director,Officer
Ownership: Direct
2026-06-24Sale
Owner: Cho, Dennis
Title: See Remarks
Shares: 14,205
Price/Share: $89.75
Value: $1,274,898.75
Shares Owned: 105,141
Relationship: Officer
Ownership: Direct
2026-06-22Sale
Owner: Cho, Dennis
Title: See Remarks
Shares: 346
Price/Share: $87.32
Value: $30,212.72
Shares Owned: 119,346
Relationship: Officer
Ownership: Direct
2026-06-22Sale
Owner: Green, Paula
Title: SVP of Human Resources
Shares: 291
Price/Share: $87.32
Value: $25,410.12
Shares Owned: 120,414
Relationship: Officer
Ownership: Direct
2026-06-22Sale
Owner: Leproust, Emily M.
Title: Chief Executive Officer
Shares: 1,688
Price/Share: $87.32
Value: $147,396.16
Shares Owned: 842,919
Relationship: Director,Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
121.55%
Inst. Shares: 74,996,411
Shares Outstanding: 61,702,000
2025-12-31
119.98%
Inst. Shares: 73,282,641
Shares Outstanding: 61,080,000
2025-09-30
120.58%
Inst. Shares: 72,114,736
Shares Outstanding: 59,808,000
2025-06-30
114.06%
Inst. Shares: 68,428,576
Shares Outstanding: 59,995,000
2025-03-31
111.75%
Inst. Shares: 66,656,459
Shares Outstanding: 59,649,000

Twist Bioscience Corp (TWST) — SEC Financial Statements & Analysis

Twist Bioscience Corp (TWST) is a biological products, (no diagnostic substances) company, incorporated in DE. Twist Bioscience Corp trades on Nasdaq as: TWST. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Twist Bioscience Corp reported a 19.19% year-over-year revenue growth, a Gross Profit Margin of 51.97% (TTM), a Debt-to-Equity ratio of 0.51x, a Price-to-Sales (P/S) ratio of 14.87x (TTM), a Price-to-Book (P/B) ratio of 14.40x (TTM), at a market cap of $6.42B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
19.19%
Gross Profit Margin TTM
51.97%
Debt To Equity
0.51x
P/S TTM
14.87x
P/B TTM
14.40x
Market Cap
$6.42B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Twist Bioscience Corp in?

Twist Bioscience Corp (TWST) operates in the Biological Products, (No Diagnostic Substances) industry.

What is TWST's market cap?

Twist Bioscience Corp (TWST) has a market capitalization of $6.42B as of 2026-06-30.

What exchange does TWST trade on?

Twist Bioscience Corp (TWST) trades on the Nasdaq.

Where is Twist Bioscience Corp incorporated?

Twist Bioscience Corp is incorporated in DE.

Wall Street's data.
Main Street's price.